Targeting uPARAP Modifies Lymphatic Vessel Architecture and Attenuates Lymphedema

Our findings provide evidence that downregulating uPARAP expression can induce a beneficial remodeling of lymphatic vasculature that attenuates lymphedema through a cell junction-based mechanism, offering a novel therapeutic pathway for lymphedema.